Gould Robert J
Related Filers (2)
Ownership (40)
4
Thursday, 6/29/2023
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/13/2023
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/29/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/8/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/11/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/5/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/17/2021
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/4/2021
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/22/2021
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/9/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/26/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/10/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/9/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/3/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/1/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/28/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/20/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/27/2020
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/18/2019
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/17/2019
Fulcrum Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/31/2015
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/10/2015
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/5/2015
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/8/2015
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/17/2015
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/4/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/3/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/4/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/5/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/3/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/4/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/5/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/8/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/12/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/30/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/6/2014
Epizyme, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/30/2013
Epizyme, Inc.: Initial statement of beneficial ownership of securities